India Gene Editing Market Outlook to 2028

India Gene Editing Market Overview

The India Gene Editing Market is currently valued at USD 80 billion based on a five-year historical analysis. This market has been primarily driven by the increasing demand for precision medicine and the rapid advancements in CRISPR technology, which allows for highly accurate gene manipulation. The healthcare sector's growing need for gene therapy, especially in treating genetic disorders, has played a significant role in expanding the gene editing market in India.

The gene editing market in India is dominated by major metropolitan regions such as Bengaluru, Hyderabad, and Mumbai. These cities are home to some of the country's leading biotechnology and pharmaceutical companies, as well as premier research institutions. The presence of specialized infrastructure, a highly skilled workforce, and significant government support in the form of biotech parks and incubators have made these cities the leading hubs for gene editing research and development.

The Indian government, through the Department of Biotechnology (DBT), recently announced an initiative to support innovative, interdisciplinary, and collaborative research approaches for agricultural improvements using genome editing.The goal is to maximize the potential of cutting-edge tools of modern biotechnology, including genome editing, to foster research and innovation focusing on translational research.

India Gene Editing Market Segmentation

By Technology: Indias gene editing market is segmented by technology into CRISPR-Cas9, TALENs, Zinc Finger Nucleases (ZFNs), and Homologous Recombination. Recently, the CRISPR-Cas9 segment has dominated the market due to its precision, ease of use, and cost-effectiveness. The CRISPR-Cas9 technology allows scientists to alter DNA with high accuracy, making it the preferred method for applications in agriculture, human therapeutics, and basic research. Furthermore, the accessibility of CRISPR to researchers across India has increased its adoption, particularly in academic and biopharma settings, which has led to its growing market share.

By Application: The India gene editing market is segmented by application into gene therapy, agriculture, livestock modification, drug discovery and development, and basic genetic research. Among these, gene therapy has emerged as the dominant application due to the rising prevalence of genetic disorders in India, such as thalassemia and sickle cell anemia, which have driven the need for targeted treatments. Additionally, the increasing awareness of personalized medicine, combined with the growing number of clinical trials in India, has further solidified gene therapy as the leading sub-segment in this market.

India Gene Editing Market Competitive Landscape

The India Gene Editing Market is characterized by a mix of large domestic players and international companies operating in the biotechnology and pharmaceutical sectors. The presence of Indian companies such as Bharat Biotech and Biocon, alongside international entities like Roche and Thermos Fisher, demonstrates the highly competitive nature of the market. These companies leverage their strong research capabilities and strategic collaborations with academic institutions to maintain their leadership positions in gene editing.

Company

Establishment Year

Headquarters

Market Focus

R&D Investment (USD)

Number of Patents

Collaborations

Revenue from Gene Editing (USD Mn)

Notable Products

Bharat Biotech

1996

Hyderabad, India

Biocon

1978

Bengaluru, India

Reliance Life Sciences

2001

Mumbai, India

Med Genome

2013

Bengaluru, India

Serum Institute of India

1966

Pune, India

India Gene Editing Market Analysis

Growth Drivers

Growing Demand for Precision Medicine: Precision medicine is increasingly relevant in India, with healthcare spending expected to surpass USD 104 billion in 2024. The rise of chronic diseases like diabetes (over 72 million cases) and cardiovascular disorders is pushing demand for gene-editing solutions that enable personalized treatment plans tailored to an individuals genetic makeup. This trend is supported by the expanding scope of precision medicine, with hospitals and research centers focusing on integrating gene therapies into mainstream treatment approaches.

Government Funding and Support for R&D: The Indian government is actively promoting research in gene-editing technologies by increasing financial backing. The Department of Biotechnology (DBT) allocated USD 1.9 billion in 2023 to life sciences research, emphasizing gene-editing innovations. Through initiatives like the National Biopharma Mission, which has received USD 250 million from the World Bank, the government is fostering advancements in CRISPR, TALEN, and other genetic technologies. This push aims to enhance Indias global standing in biotech research.

Increasing Applications in Agriculture and Livestock: Gene-editing applications in agriculture and livestock are growing in India. The country is the largest global producer of milk, with 209 million tonnes in 2023, and gene-editing technologies are being used to improve livestock breeding for higher yields and disease resistance. Additionally, gene-edited crops, such as rice and wheat, are being developed to meet the increasing food demands of over 1.4 billion people, aiming to improve food security through advancements in agricultural biotechnology.

Market Challenges

Ethical Concerns Regarding Genetic Modifications: Ethical issues continue to slow the adoption of gene-editing technologies in India. Religious and cultural concerns create public hesitations, with surveys showing that over 60% of the population is apprehensive about genetic modifications, particularly in humans. These societal concerns, combined with limited regulatory guidelines, make it challenging for market players to gain widespread acceptance of gene-editing technologies.

High Costs of Gene Editing Technologies: Gene editing is costly, with CRISPR-based research costing an estimated USD 3,000 per unit in India. These high prices are a barrier for smaller labs and institutions, restricting the use of gene-editing technologies to only a few leading research centers. While government funding is available, the infrastructure required to support large-scale projects remains a challenge for widespread accessibility.

India Gene Editing Market Future Outlook

Over the next five years, the India Gene Editing market is expected to witness significant growth driven by advancements in gene editing technologies such as CRISPR and TALEN, and the increasing adoption of gene therapies. The expansion of research facilities, rising government investment in biotech, and collaborations with international research organizations are likely to push the market forward. Furthermore, the agricultural applications of gene editing, particularly in improving crop resistance and productivity, are expected to see accelerated growth, contributing to the market's expansion.

Market Opportunities

Emerging Gene Therapy Applications: Gene therapy is gaining momentum in India, particularly in the treatment of chronic diseases and genetic disorders. With over 1.3 million new cases of cancer diagnosed annually, there is an increasing need for personalized treatments that target specific mutations. Research institutions like AIIMS are already conducting clinical trials on gene therapy applications for cancer, indicating a growing market for genetic treatments in healthcare.

Expansion in Agricultural Biotechnology: Indias agricultural biotechnology sector is seeing significant growth through the application of gene-editing technologies. As the country faces a demand for over 300 million tonnes of food grain annually, CRISPR-edited crops like rice and wheat are being developed to improve yield and pest resistance. This shift toward gene-edited agriculture could enhance productivity and sustainability, helping India address its food security challenges while boosting the agricultural economy.
Please Note: It will take 5-7 business days to complete the report upon order confirmation